← Back
$DMRA All transactions

Damora Therapeutics, Inc.

A

$ Value

$0

Shares

37,313

Price

$0

Filed

Mar 25

Insider

Name

CAIN CHRISTOPHER W.

Title

CIK

0001817733

Roles

Director

Transaction Details

Transaction Date

2026-03-23

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,313

Footnotes

This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through March 23, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date. | Under the Reporting Person's arrangement with Fairmount Funds Management LLC ("Fairmount"), the Reporting Person holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). The Reporting Person is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock. Fairmount disclaims beneficial ownership of any of the reported securities, except to the extent of its pecuniary interest therein.

Filing Info

Accession No.

0001193125-26-124466

Form Type

4

Issuer CIK

0001800315

CAIN CHRISTOPHER W.'s History

Date Ticker Type Value
2026-03-23 DMRA A $0
2025-07-01 VRDN A $0
2025-06-04 COGT A $0
2025-04-29 JBIO A $0

Other Insiders at DMRA (90d)

Insider Bought Sold Last
Landsittel Michael 2026-03-23
Jarrett Jennifer
See Remarks
2026-03-30
Turtle Cameron 2026-03-23
Fairmount Funds Management LLC 2026-03-23
Winslow Garrett
General Counsel
2026-03-23
Bruno Julianne 2026-03-23
Sattarzadeh Sherwin
Chief Operating Officer
2026-01-05